Synthesis, singlet oxygen generation, photocytotoxicity and subcellular localization of azobisporphyrins as potentially photodynamic therapeutic agentsin vitrocell study

Abstract

Three azobisporphyrins (Por1, Por2 and Por3) were synthesized by coupling two molecules of (4-nitrophenyl/pyridyl) porphyrins in the presence of KOH/butanol. The structures of porphyrins were confirmed by UV, IR, NMR and mass spectra and elemental analysis. With tetraphenylporphyrin (H2TPP) as a control, the singlet oxygen (1O[Formula: see text] generation of porphyrins was evaluated through 1,3-diphenylisobenzofuran (DPBF) method. The order of ability to generate 1O2 for three azobisporphyrins was Por 1 [Formula: see text]Por 2 > Por 3[Formula: see text] H2TPP. The photocytotoxicity and sub-cellular localization of azobisporphyrins over Hela cells were studied through MTT analysis and confocal laser scanning microscope, respectively. The results indicated Por 1 and Por 2 displayed the low dark-cytotoxicity, while Por 3 induced a concentration-dependent cytotoxicity to Hela cells with the concentration of porphyrins ranging from 1 to 100 [Formula: see text] M. With the light dose at 4 J/cm2, Por 3 killed more than 60% Hela cells at 2 [Formula: see text] M, indicating a high photocytoxicity. As seen from the laser scanning confocal microscopy images, Por 3 was mainly localized in cell membrane, while Por 1 and Por 2 do not displayed significant fluorescent emission in Hela cells. These results suggest the synthesized cationic azobisporphyrin could be used as a potential therapeutic agent for photodynamic therapy of cancers.

Carbon Dots @ Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy

“…In photodynamic therapy, photosensitizers (PSs) are irradiated by a specific wavelength of light, which triggers the generation of reactive oxygen species from intracellular oxygen that consequently induce cell death and necrosis of proximal tissues [ 3 – 6 ]. Because photosensitizers are typically harmless without light, tumor treatment can be precisely targeted by selective illumination, thus limiting damage to surrounding healthy tissues [ 7 – 9 ]. Activatable photosensitizers, such as porphyrin and phthalocyanines derivatives, have been demonstrated to possess simultaneous cancer imaging and therapy capabilities, and some of these photosensitizers have been approved for clinical use [ 10 , 11 ].…”

Self-Assembled Naphthalimide Conjugated Porphyrin Nanomaterials with D–A Structure for PDT/PTT Synergistic Therapy

“…Compared with conventional cancer treatment modalities, such as surgery, radiotherapy, and chemotherapy, phototherapy including photodynamic therapy (PDT) and photothermal therapy (PTT) is attractive due to its potential for inherent specificity and noninvasive burden . Photodynamic therapy (PDT) is one of the noninvasive therapeutic strategies, which involves the use of photosensitizers (PSs) and the generated reactive oxygen species upon light irradiation. − Under the excitation of specific wavelength light, the excited PSs will generate free radicals through electron transfer and then combine with surrounding O 2 to generate cytotoxic ROS, , such as superoxide, hydrogen peroxide, hydroxyl radicals, and singlet oxygen ( 1 O 2 ) . These short-lived reactive oxygen species can cause irreversible damage to important cellular components, such as proteins, lipids, and nucleic acids, resulting in the ablation of tumor tissue. , However, due to the limitation of tissue penetration depth, organic photosensitizers excited with visible light have not been applied to the clinical treatment of deep tumors .…”